AEterna Zentaris (AEterna Zentaris) Change In Inventory : $0.16 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is AEterna Zentaris Change In Inventory?

AEterna Zentaris's change in inventory for the quarter that ended in Dec. 2023 was $0.02 Mil. It means AEterna Zentaris's inventory declined by $0.02 Mil from Sep. 2023 to Dec. 2023 .

AEterna Zentaris's change in inventory for the fiscal year that ended in Dec. 2023 was $0.16 Mil. It means AEterna Zentaris's inventory declined by $0.16 Mil from Dec. 2022 to Dec. 2023 .

AEterna Zentaris's Total Inventories for the quarter that ended in Dec. 2023 was $0.07 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. AEterna Zentaris's Days Inventory for the quarter that ended in Dec. 2023 was 130.24.

Inventory Turnover measures how fast the company turns over its inventory within a year. AEterna Zentaris's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.70.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. AEterna Zentaris's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.65.

AEterna Zentaris Change In Inventory Historical Data

The historical data trend for AEterna Zentaris's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Change In Inventory Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.97

1.18

-0.06

-0.16

0.16

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	0.01	0.14	-	0.02

AEterna Zentaris Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

AEterna Zentaris (NAS:AEZS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AEterna Zentaris's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.0785	/	0.055	*	365 / 4
	=	130.24

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

AEterna Zentaris's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.055	/	0.0785
	=	0.70

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AEterna Zentaris's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.0785	/	0.121
	=	0.65

AEterna Zentaris Change In Inventory Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (AEterna Zentaris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (NAS:AEZS) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ET8:Germany ET8:Germany AEZS:Canada

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.